Filters

CFDP1 Antibody, Cy3 Conjugated

CFDP1 Antibody, Cy3 Conjugated size: 0.1ml 350

Supplier BIOSS PRIMARY CONJUGATED ANTIBODIES 1
Price 350
Size 0.1ml
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long name Cy3 Conjugated, CFDP1 Polyclonal Antibody
CategoryConjugated Primary Antibodies
Conjugationcy3 conjugation kit
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenCFDP1
SpecificityThis is a highly specific antibody against CFDP1
ModificationUnmodified
Modification siteNone
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
SourceKLH conjugated synthetic peptide derived from human CFDP1
Gene ID number10428
Tested applicationsIF(IHC-P)
Recommended dilutionsIF(IHC-P)(1:50-200)
Crossreactivity Mouse, Rat, Human
Crossreactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Antigen background CFDP1 is highly expressed in developing mouse teeth and is expressed at lower levels in liver, The gene encoding CFDP1 maps to human chromsome 16, There are two isoforms of CFDP1 that are produced as a result of alternative splicing events, When treated with CFDP1 peptide, in a region that has been associated with inherited craniofacial diseases, lung and heart, mouse molar teeth increase in size, such as fanconi anemia type A, whereas treating cells with against CFDP1 shows an increase in the number of apoptotic cells and gradual tooth disintegration, CFDP1 is a 299 amino acid protein that is involved in embryogenesis and normal cell function
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation Emission512, 550nm/570, 615nm
Synonyms BCNT p97 CP27 SWC5 Yeti CENP-29
Properties 1 of the CFDP1 Antibody, Conjugated can be used in flow cytometry but typically shows lower fluorescence intensity comparable to that of PE or APC, Cy3 antibodies are excited by the 488-nanometer wave of an argon laser and the 633-nanometer line of a helium-neon diode laser, This Bioss Primary Conjugated Antibodies antibody is well suited for fluorescent microscopy, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
Gene targetCFDP1 Conjugated
Short name Conjugated, CFDP1 Antibody
Technique antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelCy3
Alternative name cyanine 3 coupled, craniofacial development protein 1 (Antibody to)
Alternative techniqueantibodies
Alternative to gene target BCNT and BUCENTAUR and CENP-29 and CP27 and p97 and SWC5 and Yeti, CFDP1 and IDBG-42521 and ENSG00000153774 and 10428, CFDP1 and IDBG-629114 and ENSBTAG00000015427 and 281682, Cfdp1 and IDBG-193634 and ENSMUSG00000031954 and 23837, molecular_function, multiple, this GO :0003674 and molecular function and molecular function this GO :0005575 and cellular component and cellular component this GO :0007155 and cell adhesion and biological process this GO :0007275 and multicellular organismal development and biological process this GO :0008150 and biological process and biological process this GO :0008360 and regulation of cell shape and biological process this GO :0042127 and regulation of cell proliferation and biological process this GO :2000270 and negative regulation of fibroblast apoptotic process and biological process, this GO :0003674: molecular_function, this GO :0003674: molecular_function, craniofacial development protein 1
Identity 1873
Gene CFDP1
Long gene name craniofacial development protein 1
Synonyms name Bucentaur centromere protein 29
Locus 16q23, 1
Discovery year 1999-12-09
GenBank acession AB009285
Entrez gene record 10428
Pubmed identfication 9602175 9006920 11992732
RefSeq identity NM_006324
Havana BLAST/BLAT OTTHUMG00000137615

Similar products

Subscribe to our Newsletter